These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 8821206)

  • 1. Influence of high-dose antithrombin concentrate therapy on the release of cellular proteinases, cytokines, and soluble adhesion molecules in acute inflammation.
    Jochum M
    Semin Hematol; 1995 Oct; 32(4 Suppl 2):19-32. PubMed ID: 8821206
    [No Abstract]   [Full Text] [Related]  

  • 2. Levels of soluble adhesion molecules and cytokines in patients with septic multiple organ failure.
    Endo S; Inada K; Kasai T; Takakuwa T; Yamada Y; Koike S; Wakabayashi G; Niimi M; Taniguchi S; Yoshida M
    J Inflamm; 1995-1996; 46(4):212-9. PubMed ID: 8878795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multisystem organ failure: predicting the future.
    Gropper MA
    Anesthesiology; 2007 Jul; 107(1):6-7. PubMed ID: 17585208
    [No Abstract]   [Full Text] [Related]  

  • 4. Influence of sex and age on mods and cytokines after multiple injuries.
    Frink M; Pape HC; van Griensven M; Krettek C; Chaudry IH; Hildebrand F
    Shock; 2007 Feb; 27(2):151-6. PubMed ID: 17224789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antithrombin III in animal models of sepsis and organ failure.
    Dickneite G
    Semin Thromb Hemost; 1998; 24(1):61-9. PubMed ID: 9515781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coagulation abnormalities in acute lung injury and sepsis.
    Abraham E
    Am J Respir Cell Mol Biol; 2000 Apr; 22(4):401-4. PubMed ID: 10745020
    [No Abstract]   [Full Text] [Related]  

  • 7. Recovery of antithrombin III in patients undergoing orthotopic liver transplantation after administration of an antithrombin III concentrate.
    Scherer RU; Gödde S; Giebler RM; Schmutzler MJ; Erhard J; Kox WJ
    Semin Thromb Hemost; 1993; 19(3):309-10. PubMed ID: 8362259
    [No Abstract]   [Full Text] [Related]  

  • 8. Coagulation dysfunction in sepsis and multiple organ system failure.
    Nimah M; Brilli RJ
    Crit Care Clin; 2003 Jul; 19(3):441-58. PubMed ID: 12848314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic applications of antithrombin concentrates in systemic inflammatory disorders.
    Fourrier F
    Blood Coagul Fibrinolysis; 1998 Apr; 9 Suppl 2():S39-45. PubMed ID: 9662468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activated cytotoxic T cells and NK cells in severe sepsis and septic shock and their role in multiple organ dysfunction.
    Zeerleder S; Hack CE; Caliezi C; van Mierlo G; Eerenberg-Belmer A; Wolbink A; Wuillenmin WA
    Clin Immunol; 2005 Aug; 116(2):158-65. PubMed ID: 15993363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antithrombin deficiency in special clinical syndromes--Part II: panel discussion #2.
    Sacher R
    Semin Hematol; 1995 Oct; 32(4 Suppl 2):67-71. PubMed ID: 8821213
    [No Abstract]   [Full Text] [Related]  

  • 12. Transient red-blood-cell morphological anomalies after acute liver dysfunction.
    Lesesve JF; Garçon L; Lecompte T
    Eur J Haematol; 2010 Jan; 84(1):92-3. PubMed ID: 19624719
    [No Abstract]   [Full Text] [Related]  

  • 13. Serial changes in neutrophil-endothelial activation markers during the course of sepsis associated with disseminated intravascular coagulation.
    Gando S; Kameue T; Matsuda N; Hayakawa M; Hoshino H; Kato H
    Thromb Res; 2005; 116(2):91-100. PubMed ID: 15907522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutrophil-derived circulating free DNA (cf-DNA/NETs): a potential prognostic marker for posttraumatic development of inflammatory second hit and sepsis.
    Margraf S; Lögters T; Reipen J; Altrichter J; Scholz M; Windolf J
    Shock; 2008 Oct; 30(4):352-8. PubMed ID: 18317404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The trigger for posttraumatic multiple organ failure: surgical sepsis or inflammation?
    Nerlich ML
    Prog Clin Biol Res; 1989; 308():413-7. PubMed ID: 2780707
    [No Abstract]   [Full Text] [Related]  

  • 16. The response of antithrombin III activity after supplementation decreases in proportion to the severity of sepsis and liver dysfunction.
    Hayakawa M; Sawamura A; Yanagida Y; Sugano M; Hoshino H; Gando S
    Shock; 2008 Dec; 30(6):649-52. PubMed ID: 18496242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of antithrombin III in critical patients.
    Díaz-Cremades JM; Lorenzo R; Sánchez M; Moreno MJ; Alsar MJ; Bosch JM; Fajardo L; González D; Guerrero D
    Intensive Care Med; 1994 Nov; 20(8):577-80. PubMed ID: 7706571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. International Society on Thrombosis and Haemostasis score for overt disseminated intravascular coagulation predicts organ dysfunction and fatality in sepsis patients.
    Voves C; Wuillemin WA; Zeerleder S
    Blood Coagul Fibrinolysis; 2006 Sep; 17(6):445-51. PubMed ID: 16905947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Inflammation: biological and clinical features--management].
    Boué F
    Rev Prat; 2007 Apr; 57(7):775-80. PubMed ID: 17626324
    [No Abstract]   [Full Text] [Related]  

  • 20. [Place of antithrombin III concentrate in the intensive care of disseminated intravascular coagulation].
    Vorob'eva NA; Neporada EL; Turundaevskaia OV; Mel'nikova GN
    Anesteziol Reanimatol; 2007; (2):42-4. PubMed ID: 17563999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.